| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Laboratory Medicine and
Pathology*
and Orthopedic
Surgery,
University of Minnesota,
Minneapolis, Minnesota
Epithelial cancer of the ovary spreads by implantation of tumor cells onto the mesothelial cells lining the peritoneal cavity. The aim of this study was to identify the adhesion molecules involved in the interaction of ovarian carcinoma cells with mesothelial cells. The human ovarian carcinoma cell lines SKOV3 and NIH:OVCAR5 as well as LP9 cells, a human peritoneal mesothelial cell line, were analyzed by flow cytometry for the expression of CD44 and the ß1 integrin subunit. An in vitro adhesion assay was developed whereby LP9 cells were grown as confluent monolayers, and radiolabeled ovarian carcinoma cells were monitored for their ability to adhere to the mesothelial monolayer in the presence of potential inhibitors. Each cell line was evaluated for the presence of a pericellular matrix by a particle exclusion assay. A monoclonal antibody (MAb) against the ß1 integrin subunit significantly reduced the adhesion of SKOV3 cells to LP9 cells, whereas NIH:OVCAR5 adhesion to LP9 cells was significantly inhibited by a CD44 MAb. The LP9 cells produced both hyaluronic acid (a ligand for CD44) as well as several extracellular matrix molecules (ligands for the ß1 integrin heterodimers). These results suggest that both CD44 and the ß1 integrin heterodimers may play a role in mediating the adhesion of ovarian carcinoma cells to mesothelial cells.
This article has been cited by other articles:
 |
|
 |
|
  P. A.B. Klemmt, J. G. Carver, P. Koninckx, E. J. McVeigh, and H. J. Mardon Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression Hum. Reprod., December 1, 2007; 22(12): 3139 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Said, M. J. Socha, J. J. Olearczyk, A. A. Elmarakby, J. D. Imig, and K. Motamed Normalization of the Ovarian Cancer Microenvironment by SPARC Mol. Cancer Res., October 1, 2007; 5(10): 1015 - 1030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Said, I. Najwer, and K. Motamed Secreted Protein Acidic and Rich in Cysteine (SPARC) Inhibits Integrin-Mediated Adhesion and Growth Factor-Dependent Survival Signaling in Ovarian Cancer Am. J. Pathol., March 1, 2007; 170(3): 1054 - 1063. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sawada, A. R. Radjabi, N. Shinomiya, E. Kistner, H. Kenny, A. R. Becker, M. A. Turkyilmaz, R. Salgia, S. D. Yamada, G. F. Vande Woude, et al. c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and Invasion Cancer Res., February 15, 2007; 67(4): 1670 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gerber, V. Y. Rybalko, C. E. Bigelow, A. A. Lugade, T. H. Foster, J. G. Frelinger, and E. M. Lord Preferential Attachment of Peritoneal Tumor Metastases to Omental Immune Aggregates and Possible Role of a Unique Vascular Microenvironment in Metastatic Survival and Growth Am. J. Pathol., November 1, 2006; 169(5): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Said and K. Motamed Absence of Host-Secreted Protein Acidic and Rich in Cysteine (SPARC) Augments Peritoneal Ovarian Carcinomatosis Am. J. Pathol., December 1, 2005; 167(6): 1739 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Shiftan, T. Israely, M. Cohen, V. Frydman, H. Dafni, R. Stern, and M. Neeman Magnetic Resonance Imaging Visualization of Hyaluronidase in Ovarian Carcinoma Cancer Res., November 15, 2005; 65(22): 10316 - 10323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Wang, Y. Ngalame, M. C. Panelli, H. Nguyen-Jackson, M. Deavers, P. Mueller, W. Hu, C. A. Savary, R. Kobayashi, R. S. Freedman, et al. Peritoneal and Subperitoneal Stroma May Facilitate Regional Spread of Ovarian Cancer Clin. Cancer Res., January 1, 2005; 11(1): 113 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sillanpaa, M. A. Anttila, K. Voutilainen, R. H. Tammi, M. I. Tammi, S. V. Saarikoski, and V.-M. Kosma CD44 Expression Indicates Favorable Prognosis in Epithelial Ovarian Cancer Clin. Cancer Res., November 1, 2003; 9(14): 5318 - 5324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kajiyama, F. Kikkawa, T. Suzuki, K. Shibata, K. Ino, and S. Mizutani Prolonged Survival and Decreased Invasive Activity Attributable to Dipeptidyl Peptidase IV Overexpression in Ovarian Carcinoma Cancer Res., May 1, 2002; 62(10): 2753 - 2757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Casey, K. M. Burleson, K. M. Skubitz, S. E. Pambuccian, T. R. Oegema Jr., L. E. Ruff, and A. P. N. Skubitz {beta}1-Integrins Regulate the Formation and Adhesion of Ovarian Carcinoma Multicellular Spheroids Am. J. Pathol., December 1, 2001; 159(6): 2071 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Witz, I. A. Montoya-Rodriguez, S. Cho, V. E. Centonze, L. F. Bonewald, and R. S. Schenken Composition of the Extracellular Matrix of the Peritoneum Reproductive Sciences, September 1, 2001; 8(5): 299 - 304. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
